These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25030611)

  • 1. A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer.
    Ferrand M; Galy A; Boisgerault F
    Gene Ther; 2014 Sep; 21(9):828-39. PubMed ID: 25030611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transfer.
    Boisgerault F; Gross DA; Ferrand M; Poupiot J; Darocha S; Richard I; Galy A
    Hum Gene Ther; 2013 Apr; 24(4):393-405. PubMed ID: 23427817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.
    Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic transgene immunogenicity gears CD8(+) T-cell priming after rAAV-mediated muscle gene transfer.
    Carpentier M; Lorain S; Chappert P; Lalfer M; Hardet R; Urbain D; Peccate C; Adriouch S; Garcia L; Davoust J; Gross DA
    Mol Ther; 2015 Apr; 23(4):697-706. PubMed ID: 25492560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.
    Sarukhan A; Soudais C; Danos O; Jooss K
    J Gene Med; 2001; 3(3):260-70. PubMed ID: 11437331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.
    Fougerousse F; Bartoli M; Poupiot J; Arandel L; Durand M; Guerchet N; Gicquel E; Danos O; Richard I
    Mol Ther; 2007 Jan; 15(1):53-61. PubMed ID: 17164775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.
    Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S
    Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy.
    Wang Z; Allen JM; Riddell SR; Gregorevic P; Storb R; Tapscott SJ; Chamberlain JS; Kuhr CS
    Hum Gene Ther; 2007 Jan; 18(1):18-26. PubMed ID: 17176210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles.
    Guibinga GH; Lochmuller H; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    J Virol; 1998 Jun; 72(6):4601-9. PubMed ID: 9573223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8
    Ghenassia A; Gross DA; Lorain S; Tros F; Urbain D; Benkhelifa-Ziyyat S; Charbit A; Davoust J; Chappert P
    Mol Ther; 2017 Oct; 25(10):2309-2322. PubMed ID: 28720467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune evasion by muscle-specific gene expression in dystrophic muscle.
    Hartigan-O'Connor D; Kirk CJ; Crawford R; Mulé JJ; Chamberlain JS
    Mol Ther; 2001 Dec; 4(6):525-33. PubMed ID: 11735336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.
    Bartoli M; Poupiot J; Goyenvalle A; Perez N; Garcia L; Danos O; Richard I
    Gene Ther; 2006 Jan; 13(1):20-8. PubMed ID: 16107863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.
    Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G
    Front Immunol; 2021; 12():674242. PubMed ID: 33995418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local gene delivery and methods to control immune responses in muscles of normal and dystrophic dogs.
    Wang Z; Tapscott SJ; Storb R
    Methods Mol Biol; 2011; 709():265-75. PubMed ID: 21194034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice.
    Guttinger M; Tafi E; Battaglia M; Coletta M; Cossu G
    Exp Cell Res; 2006 Nov; 312(19):3872-9. PubMed ID: 16982052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-depleted adeno-associated virus vectors evade immune detection.
    Faust SM; Bell P; Cutler BJ; Ashley SN; Zhu Y; Rabinowitz JE; Wilson JM
    J Clin Invest; 2013 Jul; 123(7):2994-3001. PubMed ID: 23778142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated virus type 8-mediated extensive therapeutic gene delivery into skeletal muscle of alpha-sarcoglycan-deficient mice.
    Nishiyama A; Ampong BN; Ohshima S; Shin JH; Nakai H; Imamura M; Miyagoe-Suzuki Y; Okada T; Takeda S
    Hum Gene Ther; 2008 Jul; 19(7):719-30. PubMed ID: 18578595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.